Sangamo BioSciences Restructuring Creates A Pipeline Gap, Merits 87% PT Decrease
November 01, 2016 at 11:13 AM EDT
Wedbush believes Sangamo BioSciences, Inc. (NASDAQ: SGMO) lacks any upside potential until the year 2018, citing the pipeline gap in the ...